- 05-20李楠 Generalizing Biomedical Relation Classification with Neural Adversarial Domain Adaptation
- 04-23李青青 Deep learning for drug-drug interaction extraction
- 04-15刁宇峰 AAAI2018中的自注意力机制(Self-attention Mechanism)
- 04-15王治政 Label informed Attributed Network Embedding
- 03-24罗凌 自然语言处理中的自注意力机制（Self-attention Mechanism）
- 01-04任玉琪 Capsule间的动态路由
近日接到BMC Bioinformatics编辑部的通知，博士生桑盛田的论文“SemaTyP: A Knowledge Graph Based Literature Mining Method for Drug Discovery”被BMC Bioinformatics录用，该期刊是影响因子为2.448的SCI期刊。
Drug discovery is the process through which potential new medicines are identified. High-throughput screening and computer-aided drug discovery/design are the two main drug discovery methods for now, which have successfully discovered a series of drugs. However, development of new drugs is still an extremely time-consuming and expensive process. Biomedical literature contains important clues for the identification of potential treatments. It could support experts in biomedicine on their way towards new discoveries. Here, we propose a biomedical knowledge graph-based drug discovery method called SemaTyP, which discovers candidate drugs for diseases by mining published biomedical literature. We first construct a biomedical knowledge graph with the relations extracted from biomedical abstracts, then a logistic regression model is trained by learning the semantic types of paths of known drug therapies' existing in the biomedical knowledge graph, finally the learned model is used to discover drug therapies for new diseases. The experimental results show that our method could not only effectively discover new drug therapies for new diseases, but also could provide the potential mechanism of action of the candidate drugs.
In this paper we propose a novel knowledge graph based literature mining method for drug discovery. It could be a supplementary method for current drug discovery methods.